Stock Research for CERS

CERS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

CERS Stock Chart & Research Data

The CERS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CERS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


CERS Due diligence Resources & Stock Charts

The CERS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CERS Detailed Price Forecast - CNN Money CNN View CERS Detailed Summary - Google Finance
Yahoo View CERS Detailed Summary - Yahoo! Finance Zacks View CERS Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View CERS Trends & Analysis - Trade-Ideas Barrons View CERS Major Holders - Barrons
NASDAQ View CERS Call Transcripts - NASDAQ Seeking View CERS Breaking News & Analysis - Seeking Alpha
Spotlight View CERS Annual Report - CompanySpotlight.com OTC Report View CERS OTC Short Report - OTCShortReport.com
TradeKing View CERS Fundamentals - TradeKing Charts View CERS SEC Filings - Bar Chart
WSJ View Historical Prices for CERS - The WSJ Morningstar View Performance/Total Return for CERS - Morningstar
MarketWatch View the Analyst Estimates for CERS - MarketWatch CNBC View the Earnings History for CERS - CNBC
StockMarketWatch View the CERS Earnings - StockMarketWatch MacroAxis View CERS Buy or Sell Recommendations - MacroAxis
Bullish View the CERS Bullish Patterns - American Bulls Short Pains View CERS Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View CERS Stock Mentions - StockTwits PennyStocks View CERS Stock Mentions - PennyStockTweets
Twitter View CERS Stock Mentions - Twitter Invest Hub View CERS Investment Forum News - Investor Hub
Yahoo View CERS Stock Mentions - Yahoo! Message Board Seeking Alpha View CERS Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for CERS - SECform4.com Insider Cow View Insider Transactions for CERS - Insider Cow
CNBC View CERS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CERS - OTC Markets
Yahoo View Insider Transactions for CERS - Yahoo! Finance NASDAQ View Institutional Holdings for CERS - NASDAQ


Stock Charts

FinViz View CERS Stock Insight & Charts - FinViz.com StockCharts View CERS Investment Charts - StockCharts.com
BarChart View CERS Stock Overview & Charts - BarChart Trading View View CERS User Generated Charts - Trading View


Latest Financial News for CERS

Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association
Posted on Friday June 15, 2018

Cerus Corporation announced that results from SPARC, the Company’s European Phase 3 study evaluating the efficacy and safety of INTERCEPT-treated red blood cells in thalassemia major patients, were presented today at the 23rd Congress of European Hematology Association in Stockholm Sweden in a poster presentation entitled, “A Randomized, Controlled, Phase III Study to Evaluate S-303/Glutathione Pathogen-Inactivated ...


Cerus Announces Presentations Highlighting INTERCEPT Blood Systems at the 35th International Congress of the International Society of Blood Transfusion
Posted on Friday June 01, 2018

Cerus Corporation today announced that it will make multiple presentations, including two oral abstracts, that will be featured at the 35th International Congress of the International Society of Blood Transfusion in Toronto, Canada from June 2nd to June 6th, 2018.


Audentes Therapeutics and Three More Stocks Under Scanner in the Biotech Space
Posted on Friday May 18, 2018

LONDON, UK / ACCESSWIRE / May 18, 2018 / If you want a free Stock Review on AVEO, CLDX, and CERS sign up now at www.wallstequities.com/registration. This Friday, WallStEquities.com has initiated reports coverage on the following Biotechnology equities: Audentes Therapeutics Inc. (NASDAQ: BOLD), AVEO Pharmaceuticals Inc. (NASDAQ: AVEO), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Cerus Corp. (NASDAQ: CERS).


Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells
Posted on Wednesday May 16, 2018

Cerus Corporation (CERS) today announced an amendment to the Company’s contract with the Biomedical Advanced Research and Development Authority (BARDA). The expansion of the agreement provides an additional $15 million in funding for supplementary support of both the ReCePI acute anemia clinical trial and SCient chronic anemia clinical trial. “BARDA is an important partner in our mission to establish INTERCEPT as the standard of care for all transfused blood components globally,” said Dr. Richard Benjamin, Cerus’ chief medical officer.


Enter a stock symbol to view the stock details.